| 摘要: |
| 肝脏疾病与免疫调节异常及代谢功能障碍密切相关。巨噬细胞作为核心免疫细胞,其功能受代谢重编程精准调控,并推动疾病沿“急性损伤-慢性炎症-纤维化-肝癌”进程演进。然而,疾病不同阶段的特征性微环境如何通过巨噬细胞代谢重编程调控其表型与疾病转归,目前仍缺乏系统阐释。基于此,本文重点探讨不同阶段肝脏病理微环境如何通过影响巨噬细胞代谢途径,调控其促炎与抗炎表型平衡,进而决定疾病进展或修复结局;并总结目前靶向巨噬细胞代谢重编程的治疗策略,以期为代谢导向的肝脏疾病治疗提供理论依据。 |
| 关键词: 肝脏疾病 巨噬细胞 代谢重编程 免疫代谢 炎症 抗肿瘤免疫 |
| DOI:10.13506/j.cnki.jpr.2026.07.012 |
| 基金项目:国家自然科学基金项目(No.82273968) |
|
收稿日期:2026-01-19
修回日期:2026-03-02
出版日期:2026-07-31
|
|
| Microenvironmental regulation of macrophage metabolic reprogramming in liver disease and targeted therapeutic strategies |
| YANG Qingjuan,WU Hongxi |
| (School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China) |
| Abstract: |
| Liver diseases closely link to immune dysregulation and metabolic dysfunction. Macrophages, serving as central immune effector cells, dynamically adjust their metabolic programs to control functional responses, thereby propelling pathological progression through sequential stages of acute injury, chronic inflammation, fibrosis, and hepatocellular carcinoma. However, a systematic understanding of how stage-specific microenvironment regulates macrophage phenotypes and clinical outcome via metabolic reprogramming remains incomplete. Therefore, this review systematically examined how the pathological microenvironment at different disease stages influences macrophage metabolism, thereby modulating the balance between pro-inflammatory and anti-inflammatory phenotypes and ultimately shaping disease progression or repair. Furthermore, current therapeutic strategies targeting macrophage metabolic reprogramming were summarized, to provide a theoretical basis for developing metabolism-guided treatments for liver diseases. |
| Key words: Liver diseases Macrophages Metabolic reprogramming Immunometabolism Inflammatory Antitumor immunity |